+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Leukapheresis Market Size, Share & Trends Analysis Report By Product Type (Leukapheresis Devices, Leukapheresis Disposables), By Application (Research Application, Therapeutic Application), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 5990635
Description Jump to:
The global leukapheresis market size was estimated at USD 211.3 million in 2024 and is projected to grow at a CAGR of 11.05% from 2025 to 2030. The increasing prevalence of blood disorders and autoimmune diseases, technological advancements in leukapheresis procedures, and growing demand for personalized medicine are expected to drive the market growth. Moreover, the increasing investments in research and development activities are further contributing to the market growth.

The rising incidence of blood disorders like leukemia, lymphoma, and autoimmune diseases such as rheumatoid arthritis and multiple sclerosis are significantly driving the market growth. For instance, the Leukemia & Lymphoma Society reports that an estimated total of 184,720 people in the U.S. are expected to receive a diagnosis of leukemia, lymphoma, or myeloma in 2023. Similarly, in May 2023, a study in The Lancet involving 22 million people found autoimmune disorders affect 1 in 10 individuals, highlighting the influence of socioeconomic, seasonal, and regional factors and offers insights into the causes of these diseases, including Rheumatoid arthritis, Type 1 diabetes, and Multiple sclerosis. Thus, propelling the demand for leukapheresis over the forecast period.

The advancements in leukapheresis technologies are improving the efficiency, safety, and outcomes of the procedure. The introduction of automated systems, continuous flow centrifugation systems, and closed-system devices is expected to enhance the precision and effectiveness of leukapheresis. Thereby reducing the procedure times, minimizing donor discomfort, and optimizing cell collection yields. In October 2022, the Clinical Applications Committee of The American Society for Apheresis (ASFA), along with the IEC Therapy Subcommittee, AABB, and various other organizations, prepared a white paper. This document outlines guidelines for performing leukapheresis to retrieve mononuclear cells from pediatric and adult patients who are part of immune effector cell therapies, whether for commercial endeavors or research initiatives. Thus, anticipated to propel the market growth over the forecast period.

The shift towards personalized medicine approaches that tailor treatment strategies to individual patient profiles is fueling the demand for leukapheresis procedures. Leukapheresis plays a crucial role in cell-based therapies, such as chimeric antigen receptor (CAR) T-cell therapy and stem cell transplantation. In December 2023, an article in Transfusion and Apheresis Science underscored the challenges in manufacturing CAR-T cells, beginning with the extraction of T cells through leukapheresis from peripheral blood. The article emphasized the critical role of an effective leukapheresis product in achieving successful CAR-T cell therapy and highlighted the significance of comprehending the factors that impact T cell quality.

Global Leukapheresis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global leukapheresis market report based on product type, application, end-use, and region:

Product Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Leukapheresis Devices
  • Centrifugal Devices
  • Membrane Separators
  • Leukapheresis Disposables

Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Research Application
  • Cancer Research
  • Immunology Research
  • Others
  • Therapeutics Application
  • Hematologic Disorders
  • Autoimmune Diseases
  • Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Blood Centers
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics

Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Type
1.2.2. Application
1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Leukapheresis Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. The increasing prevalence of blood disorders and autoimmune diseases
3.2.1.2. Technological advancements in leukapheresis procedures
3.2.1.3. Growing demand for personalized medicine
3.2.1.4. Rising investments in research
3.2.2. Market restraint analysis
3.2.2.1. High equipment costs
3.3. Leukapheresis Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Leukapheresis Market: Product Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Leukapheresis Market Product Type Movement Analysis
4.3. Global Leukapheresis Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
4.4. Leukapheresis Devices
4.4.1. Leukapheresis devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Centrifugal Devices
4.4.2.1. Centrifugal Devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Membrane Separators
4.4.3.1. Membrane separators market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Leukapheresis Disposables
4.5.1. Leukapheresis disposables market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Leukapheresis Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Leukapheresis Market Application Movement Analysis
5.3. Global Leukapheresis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Research Application
5.4.1. Research application market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Cancer Research
5.4.2.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3. Immunology Research
5.4.3.1. Immunology research market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Therapeutics Application
5.5.1. Therapeutics application market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.2. Hematologic Disorders
5.5.2.1. Hematologic disorders market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.3. I Autoimmune Diseases
5.5.3.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.4. Others
5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Leukapheresis Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Leukapheresis Market End Use Movement Analysis
6.3. Global Leukapheresis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Blood Centers
6.4.1. Blood centers institutes market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Pharmaceutical & Biotechnology Companies
6.6.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Hospitals & Clinics
6.7.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Leukapheresis Market: Regional Estimates & Trend Analysis by Product Type, Application, and End Use
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive scenario
7.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Norway
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Denmark
7.5.9.1. Key country dynamics
7.5.9.2. Regulatory framework
7.5.9.3. Competitive scenario
7.5.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory framework
7.8.5.3. Competitive scenario
7.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Charles River Laboratories International, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Adacyte Therapeutics
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. AllCells, LLC
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Asahi Kasei Medical
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Haemonetics Corporation
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Macopharma
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Cerus Corporation
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. SB-Kawasumi Laboratories, Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. StemExpress, LLC.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Caltag Medsystems Limited
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. Lonza Group AG
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. ZenBio
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. Terumo BCT, Inc.
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
8.4.14. Macopharma SA
8.4.14.1. Company overview
8.4.14.2. Financial performance
8.4.14.3. Product benchmarking
8.4.14.4. Strategic initiatives
8.4.15. Miltenyi Biotec
8.4.15.1. Company overview
8.4.15.2. Financial performance
8.4.15.3. Product benchmarking
8.4.15.4. Strategic initiatives
8.4.16. Fresenius SE & Co. KGaA
8.4.16.1. Company overview
8.4.16.2. Financial performance
8.4.16.3. Product benchmarking
8.4.16.4. Strategic initiatives
8.4.17. Guangzhou Daji Medical Science
8.4.17.1. Company overview
8.4.17.2. Financial performance
8.4.17.3. Product benchmarking
8.4.17.4. Strategic initiatives
8.4.18. MEDICA S.p.A
8.4.18.1. Company overview
8.4.18.2. Financial performance
8.4.18.3. Product benchmarking
8.4.18.4. Strategic initiatives
8.4.19. SB-Kawasumi Laboratories, Inc.
8.4.19.1. Company overview
8.4.19.2. Financial performance
8.4.19.3. Product benchmarking
8.4.19.4. Strategic initiatives
8.4.20. PuriBlood Medical Co. Ltd.
8.4.20.1. Company overview
8.4.20.2. Financial performance
8.4.20.3. Product benchmarking
8.4.20.4. Strategic initiatives
8.4.21. Beijing ZKSK Technology Co. Ltd.
8.4.21.1. Company overview
8.4.21.2. Financial performance
8.4.21.3. Product benchmarking
8.4.21.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global leukapheresis market, by region, 2018 - 2030 (USD Million)
Table 3 Global leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 4 Global leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 5 Global leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 6 North America leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 7 North America leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 8 North America leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 9 North America leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 11 U.S. leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 14 Canada leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 15 Canada leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 17 Mexico leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 20 Europe leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 21 Europe leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 22 Europe leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 24 Germany leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 25 Germany leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 26 UK leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 27 UK leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 28 UK leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 29 France leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 30 France leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 31 France leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 33 Italy leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 34 Italy leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 36 Spain leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 37 Spain leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 38 Denmark leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 39 Denmark leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 42 Sweden leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 44 Norway leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 45 Norway leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 46 Norway leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 51 China leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 52 China leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 53 China leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 54 Japan leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 55 Japan leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 56 Japan leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 57 India leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 58 India leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 59 India leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 60 South Korea leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 61 South Korea leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 62 South Korea leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 63 Australia leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 64 Australia leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 65 Australia leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 67 Thailand leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 71 Latin America leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 72 Latin America leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 73 Brazil leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 74 Brazil leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 76 Argentina leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 77 Argentina leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 79 MEA leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 80 MEA leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 81 MEA leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 82 MEA leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 83 South Africa leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 84 South Africa leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 89 UAE leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 90 UAE leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 91 UAE leukapheresis market, by end use, 2018 - 2030 (USD Million)
Table 92 Kuwait leukapheresis market, by product type, 2018 - 2030 (USD Million)
Table 93 Kuwait leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait leukapheresis market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Leukapheresis market: Market outlook
Fig. 5 Leukapheresis market: Segment outlook
Fig. 6 Leukapheresis market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Leukapheresis market driver impact
Fig. 9 Leukapheresis market restraint impact
Fig. 10 Leukapheresis market: Product type outlook and key takeaways
Fig. 11 Leukapheresis market: Product type movement analysis
Fig. 12 Leukapheresis devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Centrifugal devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Membrane separators market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Leukapheresis disposables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Leukapheresis market: Application outlook and key takeaways
Fig. 17 Leukapheresis market: Application movement analysis
Fig. 18 Research application market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Immunology research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Therapeutics application market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 23 Hematologic disorders market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 24 Autoimmune diseases market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 26 Leukapheresis market: End use outlook and key takeaways
Fig. 27 Leukapheresis market: End use movement analysis
Fig. 28 Blood centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Global leukapheresis market: Regional outlook and key takeaways
Fig. 33 Global leukapheresis market: Regional movement analysis
Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Charles River Laboratories International, Inc.
  • Adacyte Therapeutics
  • AllCells, LLC
  • Asahi Kasei Medical
  • Haemonetics Corporation
  • Macopharma
  • Cerus Corporation
  • SB-Kawasumi Laboratories, Inc.
  • StemExpress, LLC.
  • Haemonetics Corporation
  • Caltag Medsystems Limited
  • Lonza Group AG
  • ZenBio
  • Terumo BCT, Inc.
  • Macopharma SA
  • Miltenyi Biotec
  • Fresenius SE & Co. KGaA
  • Guangzhou Daji Medical Science
  • MEDICA S.p.A
  • PuriBlood Medical Co. Ltd.
  • Beijing ZKSK Technology Co. Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedJanuary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 211.3 Million
Forecasted Market Value ( USD ) by 2030 $ 394.1 Million
Compound Annual Growth Rate11.0%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Leukapheresis Market by Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Leukapheresis Market by Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Leukapheresis Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Leukapheresis Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 157 Pages
  • Global
From
Leukapheresis - Global Strategic Business Report - Product Image

Leukapheresis - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Leukapheresis Market by Product, by Application, by End-User, and By Region - Product Image

Leukapheresis Market by Product, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Leukapheresis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Leukapheresis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.